TMCnet News
2016 Europe Nucleic Acid Testing/NAT Market Report - Research and MarketsResearch and Markets (http://www.researchandmarkets.com/research/dvnh4k/2016_europe) has announced the addition of the "2016 Europe Nucleic Acid Testing/NAT Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities" report to their offering. This new 1,273-page comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years. The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The ext five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years. Table of Contents I. Introduction II. Worldwide Technology and Market Overview A. DNA Sequencing B. DNA and RNA Probes Technology C. Detection Technologies D. Instrumentation Review E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip F. Pharmacogenomics G. Major Applications III. France IV. Germany V. Italy VI. Spain VII. U.K. VIII. Major Product Development Opportunities IX. Design Criteria for Decentralized Testing Products X. Alternative Market Penetration Strategies XI. Potential Market Entry Barriers and Risks XII. Competitive Assessments XIII. Appendix Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher (News - Alert) - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diade For more information visit http://www.researchandmarkets.com/research/dvnh4k/2016_europe
View source version on businesswire.com: http://www.businesswire.com/news/home/20160201005459/en/ |
